Edition:
United States

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

4.56USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$4.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
376,716
52-wk High
$8.37
52-wk Low
$4.33

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.18 December 12 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 3
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.44 2.44 2.44 2.44

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 6 17.53 18.55 16.90 24.65
Quarter Ending Mar-18 3 24.11 28.31 19.69 27.98
Year Ending Dec-17 7 59.96 62.74 58.86 57.98
Year Ending Dec-18 8 119.29 177.60 94.50 130.21
Earnings (per share)
Quarter Ending Dec-17 7 -0.18 -0.12 -0.22 -0.06
Quarter Ending Mar-18 5 -0.13 -0.09 -0.18 0.03
Year Ending Dec-17 7 -1.35 -1.30 -1.40 -0.62
Year Ending Dec-18 7 -0.41 -0.30 -0.55 -0.12

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 17.88 15.00 2.88 16.13
Quarter Ending Jun-17 14.51 15.14 0.63 4.34
Quarter Ending Mar-17 10.29 11.82 1.53 14.88
Quarter Ending Dec-16 8.41 9.53 1.12 13.30
Quarter Ending Sep-16 5.45 6.34 0.89 16.33
Earnings (per share)
Quarter Ending Sep-17 -0.18 -0.20 0.02 -12.42
Quarter Ending Jun-17 -0.18 -0.77 0.59 -324.71
Quarter Ending Mar-17 -0.20 -0.21 0.01 -3.86
Quarter Ending Dec-16 -0.25 -0.32 0.07 -28.00
Quarter Ending Sep-16 -0.20 -0.39 0.19 -91.83

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 17.53 17.53 18.54 22.32 24.65
Quarter Ending Mar-18 24.11 24.11 24.11 28.57 27.98
Year Ending Dec-17 59.96 59.96 63.55 69.22 57.98
Year Ending Dec-18 119.29 119.29 125.21 138.70 130.21
Earnings (per share)
Quarter Ending Dec-17 -0.18 -0.18 -0.17 -0.16 -0.06
Quarter Ending Mar-18 -0.13 -0.13 -0.12 -0.10 0.03
Year Ending Dec-17 -1.35 -1.35 -1.34 -1.32 -0.62
Year Ending Dec-18 -0.41 -0.41 -0.37 -0.32 -0.12

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 1
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 2
Year Ending Dec-18 0 0 0 2
Earnings
Quarter Ending Dec-17 0 0 0 1
Quarter Ending Mar-18 0 0 0 1
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 0 1